Advanced Search

Study Preview



Study Title and Description

Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
Author Palacios S., Farias ML., Luebbert H., Gomez G., Yabur JA., Quail DC., Turbi C., Kayath MJ., Almeida MJ., Mönnig E., Nickelsen T.
Country Instituto Palacios, Madrid, Spain.
Year 2004
Numbers Pubmed ID: 15295352

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.